Search results for "Prostate cancer risk"

showing 4 items of 4 documents

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.

2014

Background: Toll-like receptor 4 (TLR4) is one of the best known TLR members expressed on the surface of several leukocytes and tissue cells and has a key function in detecting pathogen and danger-associated molecular patterns. The role of TLR4 in the pathophysiology of several age-related diseases is also well recognized, such as prostate cancer (PCa). TLR4 polymorphisms have been related to PCa risk, but the relationship between TLR4 genotypes and aggressive PCa risk has not been evaluated by any systematic reviews. Methods: We performed a systematic review and meta-analysis of candidate-gene and genome-wide association studies analyzing this relationship and included only white populatio…

MaleProstate cancer polymorphisms of TLR4 aggressive prostate cancer risk meta-analysisSystematic Reviewslcsh:MedicineGenome-wide association studySingle-nucleotide polymorphismBiologyResearch and Analysis MethodsBioinformaticsPolymorphism Single NucleotideProstate cancerGenotypeGeneticsCancer GeneticsmedicineHumansSettore MED/05 - Patologia ClinicaGenetic Predisposition to DiseaseStatistical Methodslcsh:ScienceGenotypingGenetic associationEvolutionary BiologyMultidisciplinarylcsh:RProstatic NeoplasmsBiology and Life SciencesResearch Assessmentmedicine.diseaseImmunity InnateToll-Like Receptor 4Systematic reviewMeta-analysisPhysical SciencesGenetic Polymorphismlcsh:QPopulation GeneticsMathematicsStatistics (Mathematics)Genome-Wide Association StudyResearch ArticleMeta-AnalysisPLoS ONE
researchProduct

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

2021

Simple Summary Current cancer testing gene panels tend to be comprehensive. One of the genes commonly included in the testing panels is BARD1. To establish whether BARD1 mutations predispose to prostate cancer, we sequenced BARD1 in 390 hereditary prostate cancer cases, genotyped 5715 men with unselected prostate cancer and 10,252 controls for three recurrent rare BARD1 variants in Poland. We did not see an elevated prostate risk cancer given p.Q564X truncating mutation, p.R658C missense mutation and p.R659= synonymous variant. Neither variant influenced prostate cancer characteristics or survival. Our study is the first to evaluate the association between BARD1 mutations and prostate cance…

OncologyCancer Researchmedicine.medical_specialtySusceptibility genemedicine.disease_causesurvivalArticleProstate cancerBreast cancerBARD1; mutation; prostate cancer; risk; survivalInternal medicineBARD1medicineBARD1GeneRC254-282riskProstate cancer riskMutationbusiness.industryCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseprostate cancerOncology<i>BARD1</i>mutationbusinessCancers
researchProduct

Lifetime total and beverage specific - alcohol intake and prostate cancer risk: a case-control study

2004

Abstract Background We investigated lifetime alcohol consumption and prostate cancer risk in a case-control study conducted in Buffalo, NY (1998–2001). Methods The study included 88 men, aged 45 to 85 years with incident, histologically-confirmed prostate cancer and 272 controls. We conducted extensive in-person interviews regarding lifetime alcohol consumption and other epidemiologic data. Results Prostate cancer risk was not associated with lifetime intake of total and beverage specific ethanol. In addition we found no association with number of drinks per day (average drinks per day over the lifetime) or drinks per drinking day (average drinks per day on drinking days only over the lifet…

Prostate cancer riskNutrition and Dieteticsbusiness.industryCase-control studyMedicine (miscellaneous)Case Reportlcsh:TX341-641Clinical nutritionmedicine.disease3. Good health03 medical and health sciencesProstate cancerlcsh:Nutritional diseases. Deficiency diseases0302 clinical medicine030220 oncology & carcinogenesisEnvironmental healthEtiologyMedicineAlcohol intake030212 general & internal medicineEpidemiologic databusinessAlcohol consumptionlcsh:Nutrition. Foods and food supplylcsh:RC620-627Nutrition Journal
researchProduct

Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data

2015

The paper describes the use of frequentist and Bayesian shared-parameter joint models of longitudinal measurements of prostate-specific antigen (PSA) and the risk of prostate cancer (PCa). The motivating dataset corresponds to the screening arm of the Spanish branch of the European Randomized Screening for Prostate Cancer study. The results show that PSA is highly associated with the risk of being diagnosed with PCa and that there is an age-varying effect of PSA on PCa risk. Both the frequentist and Bayesian paradigms produced very close parameter estimates and subsequent 95% confidence and credibility intervals. Dynamic estimations of disease-free probabilities obtained using Bayesian infe…

Statistics and ProbabilityPREDICTIONBayesian probabilityurologic and male genital diseasesBayesian inferenceGeneralized linear mixed modelPSAProstate cancerLATENT CLASS MODELSAnàlisi de supervivència (Biometria)Frequentist inference62N01Statisticsprostate cancer screeningSurvival analysis (Biometry)FAILUREMedicineProstate cancer riskTO-EVENT DATAbusiness.industryjoint modelsMORTALITYDISEASE PROGRESSIONmedicine.diseaselinear mixed modelsTIMEProstate-specific antigenProstate cancer screeningshared-parameter models:Matemàtiques i estadística::Estadística matemàtica [Àrees temàtiques de la UPC]62P10SURVIVALStatistics Probability and Uncertaintyrelative risk modelsFOLLOW-UPbusinessJournal of Applied Statistics
researchProduct